ACADIA Pharmaceuticals Statistics
Total Valuation
ACAD has a market cap or net worth of $3.85 billion. The enterprise value is $3.08 billion.
Important Dates
The last earnings date was Wednesday, February 25, 2026, after market close.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ACAD has 170.49 million shares outstanding. The number of shares has increased by 2.14% in one year.
| Current Share Class | 170.49M |
| Shares Outstanding | 170.49M |
| Shares Change (YoY) | +2.14% |
| Shares Change (QoQ) | +0.42% |
| Owned by Insiders (%) | 0.56% |
| Owned by Institutions (%) | 73.04% |
| Float | 126.64M |
Valuation Ratios
The trailing PE ratio is 9.82 and the forward PE ratio is 45.48.
| PE Ratio | 9.82 |
| Forward PE | 45.48 |
| PS Ratio | 3.59 |
| Forward PS | 3.00 |
| PB Ratio | 3.13 |
| P/TBV Ratio | 3.44 |
| P/FCF Ratio | 36.61 |
| P/OCF Ratio | 35.05 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 26.44, with an EV/FCF ratio of 29.31.
| EV / Earnings | 7.88 |
| EV / Sales | 2.88 |
| EV / EBITDA | 26.44 |
| EV / EBIT | 29.41 |
| EV / FCF | 29.31 |
Financial Position
The company has a current ratio of 3.83, with a Debt / Equity ratio of 0.04.
| Current Ratio | 3.83 |
| Quick Ratio | 3.49 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.40 |
| Debt / FCF | 0.50 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 39.89% and return on invested capital (ROIC) is 35.84%.
| Return on Equity (ROE) | 39.89% |
| Return on Assets (ROA) | 4.76% |
| Return on Invested Capital (ROIC) | 35.84% |
| Return on Capital Employed (ROCE) | 8.14% |
| Weighted Average Cost of Capital (WACC) | 8.57% |
| Revenue Per Employee | $1.34M |
| Profits Per Employee | $489,975 |
| Employee Count | 798 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 14.76 |
Taxes
| Income Tax | -252.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.59% in the last 52 weeks. The beta is 0.81, so ACAD's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +28.59% |
| 50-Day Moving Average | 25.08 |
| 200-Day Moving Average | 23.78 |
| Relative Strength Index (RSI) | 41.44 |
| Average Volume (20 Days) | 1,857,177 |
Short Selling Information
The latest short interest is 8.90 million, so 5.22% of the outstanding shares have been sold short.
| Short Interest | 8.90M |
| Short Previous Month | 9.31M |
| Short % of Shares Out | 5.22% |
| Short % of Float | 7.03% |
| Short Ratio (days to cover) | 6.76 |
Income Statement
In the last 12 months, ACAD had revenue of $1.07 billion and earned $391.00 million in profits. Earnings per share was $2.30.
| Revenue | 1.07B |
| Gross Profit | 653.71M |
| Operating Income | 104.81M |
| Pretax Income | 138.90M |
| Net Income | 391.00M |
| EBITDA | 116.57M |
| EBIT | 104.81M |
| Earnings Per Share (EPS) | $2.30 |
Full Income StatementBalance Sheet
The company has $819.69 million in cash and $52.19 million in debt, with a net cash position of $767.50 million or $4.50 per share.
| Cash & Cash Equivalents | 819.69M |
| Total Debt | 52.19M |
| Net Cash | 767.50M |
| Net Cash Per Share | $4.50 |
| Equity (Book Value) | 1.23B |
| Book Value Per Share | 7.21 |
| Working Capital | 785.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $109.84 million and capital expenditures -$4.69 million, giving a free cash flow of $105.15 million.
| Operating Cash Flow | 109.84M |
| Capital Expenditures | -4.69M |
| Free Cash Flow | 105.15M |
| FCF Per Share | $0.62 |
Full Cash Flow StatementMargins
Gross margin is 61.01%, with operating and profit margins of 9.78% and 36.49%.
| Gross Margin | 61.01% |
| Operating Margin | 9.78% |
| Pretax Margin | 12.96% |
| Profit Margin | 36.49% |
| EBITDA Margin | 10.88% |
| EBIT Margin | 9.78% |
| FCF Margin | 9.81% |
Dividends & Yields
ACAD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.14% |
| Shareholder Yield | -2.14% |
| Earnings Yield | 10.16% |
| FCF Yield | 2.73% |
Analyst Forecast
The average price target for ACAD is $30.45, which is 34.85% higher than the current price. The consensus rating is "Buy".
| Price Target | $30.45 |
| Price Target Difference | 34.85% |
| Analyst Consensus | Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (5Y) | 11.82% |
| EPS Growth Forecast (5Y) | 6.52% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ACAD has an Altman Z-Score of 6.21 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.21 |
| Piotroski F-Score | 5 |
